Clinical trial · Interventional
Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Research purpose: Lymphedema is a very common complication in breast cancer patients. However, since there is currently no curable treatment, it is important to prevent and reduce the severity of lymphedema. The purpose of this study is to evaluate whether preoperative exercise is effective in preventing lymphedema after surgery. For secondary outcome, the preventive effects of exercise on other upper extremity dysfunctions (eg. pectoralis tightness, Axillary web syndrome, Adhesive capsulitis), which are common in breast cancer patients, were assessed.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Aerobic exercise, Strength training, Flexibility exercise | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention group
- description
- Individually tailored exercise consisting of aerobic, strength, and flexibility exercises is prescribed, self-exercise compliance monitoring through an application, and diet management education through nutritional counseling.
- interventionNames
- Behavioral: Aerobic exercise, Strength training, Flexibility exercise
- type
- NO_INTERVENTION
- label
- Control group
- description
- One session of flexibility exercise education, diet management education through nutritional counseling
Primary outcomes (2)
- measure
- Bilateral upper limb volume
- timeFrame
- Immediately, Preoperatively, 1 month, 3 months, 6 months.
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Patients aged 20 or older and younger than 80 who were first diagnosed with breast cancer * Patients scheduled for surgery and starting neoadjuvant chemotherapy before surgery Exclusion Criteria: * Patients with medical contraindications to exercise intervention or pain or musculoskeletal conditions that may limit active exercise intervention
References
Publications (0)
Data not yet available